In this episode, we dig into peptides—why they’re suddenly everywhere, why people are trying them, and why the online conversation often feels worlds apart from the medical one. We zoom out from the hype to explore what peptides actually are, why some have become blockbuster therapies, and how a mix of optimization culture, mistrust of institutions, and access issues has fueled a booming gray market. We also explore the key questions we think everyone should be asking before trying anything that’s framed as “natural,” “risk-free,” or “not really a drug,” and we discuss what this trend can teach us about informed consent, patient autonomy, and where medicine may be headed next.

00:00 Podcast intro
01:18 Meet the hosts
01:21 Peptides topic setup
02:01 Patient longevity story
03:39 Why peptides hype
05:11 Natural fallacy talk
06:50 What is a peptide
08:19 Peptide drugs history
10:47 Why peptides booming
12:06 Legal gray areas
13:55 Why it went viral
14:50 Optimization culture
16:35 Distrust and marketing
20:14 K shaped economy angle
24:37 Nugget of truth
26:44 Peptides are drugs
28:56 Gray market risks
31:30 Evidence categories
32:49 FDA approved examples
33:22 Immune booster peptide
34:14 Growth Hormone Peptides
35:00 Side Effects Reality Check
36:49 Statins Versus Hype
37:54 Retatrutide Triple Agonist
38:59 Wolverine Stack Breakdown
39:31 BPC 157 Claims
40:35 TB 500 No Human Data
43:17 Regulation Versus Wild West
45:11 Why Patients Take Risks
46:42 Doctoring With Empathy
50:26 Informed Consent Gaps
52:55 Framing Changes Decisions
55:39 Peptides Future Outlook
58:26 Fund Studies Faster
01:00:05 Wrap Up And Disclaimer

📖 Read the full episode summary, sources, and resources on our Substack:
👉www.theantisocialdoctors.com